Research Applications for Striatech Products

CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke

Mechanical, ischemic, and blast injuries that drive rapid, often irreversible damage to CNS neurons and axons. Optic nerve crush, retinal I/R, and TBI models share core injury cascades and yield directly quantifiable visual outcomes.
Introduction

What is CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke?

CNS trauma and acute injury encompasses mechanical, ischemic, and blast-force insults that produce rapid, often irreversible damage to neurons and their axonal projections. In preclinical research, three paradigms dominate this application area: optic nerve crush and transection, which directly sever or compress the optic nerve as a tractable in vivo model of CNS white matter axon injury, retinal ischemia-reperfusion (I/R) injury, in which acute intraocular pressure elevation followed by release replicates the pathophysiology of retinal artery or vein occlusion and ischemic optic neuropathy and traumatic brain injury (TBI), including blast exposure, which produces retinal and visual pathway damage as secondary but diagnostically and mechanistically significant sequelae of CNS trauma. Each paradigm activates overlapping injury cascades – primary axon degeneration, excitotoxic retinal ganglion cell (RGC) death, neuroinflammatory amplification via microglia and complement, oxidative stress, and neurovascular barrier breakdown – that mirror mechanisms operating across the injured CNS. The optic nerve holds a unique dual identity in CNS trauma research: it is simultaneously the most clinically relevant output of the retina and a genuine CNS white matter tract whose injury biology is directly informative for spinal cord, corpus callosum, and brainstem axon research. This dual nature makes optic nerve injury models among the most productive and reproducible paradigms in the CNS trauma toolkit. Critically, because the retina is the only CNS tissue directly accessible to non-invasive optical examination in the living animal, injury to this system offers researchers the rare opportunity to track neuronal and axonal degeneration in real time using behavioral, electrophysiological, and imaging endpoints without terminal intervention. Acute CNS injury is also a gateway to understanding chronic neurodegeneration. Secondary degeneration spreading from an acute insult recapitulates mechanisms implicated in glaucoma, Alzheimer's disease, and multiple sclerosis, and many neuroprotective strategies validated in acute injury models have direct translational relevance to chronic disease. Researchers working across the CNS trauma, neuroregeneration, and neuroprotection fields will find that behavioral visual endpoints provide a sensitive, non-invasive window onto the functional consequences of injury and the efficacy of therapeutic intervention.
Vision: A Window into the brain 

Why Are Visual Endpoints Relevant in CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke Research?

Even when the eye is not the primary target, acute CNS trauma frequently impairs the visual pathway in ways that are both diagnostically informative and scientifically exploitable. If your primary research subject is TBI, stroke, spinal cord injury, or systemic ischemia, the following points explain why visual function readouts are directly relevant to your work. The retina is embryologically, anatomically, and molecularly a CNS tissue. RGCs are central neurons whose axons form the optic nerve, a white matter tract with the same molecular composition, myelination pattern, and injury vulnerability as tracts in the brain and spinal cord. When blast force, intracranial pressure waves, or ischemia propagate through the CNS, RGC loss and axon degeneration in the optic nerve follow the same time course and molecular sequence as damage in non-visual CNS regions. Studies using murine blast-TBI models have documented dose-dependent RGC loss and quantifiable optomotor deficits, even when gross neurological scoring shows no overt motor impairment (Harper et al, 2024, Exp Eye Res). Similarly, retinal ischemia-reperfusion injury co-activates complement, RIPK1-driven necroptosis, and TNF-alpha-mediated inflammatory cascades (Zhao et al, 2025, IOVS)(Kim et al, 2024, Cell Death Differ) that are identical to those documented in cerebral ischemia and TBI. For researchers studying stroke or systemic ischemia, neurovascular injury associated with these conditions produces measurable visual function deficits detectable by optomotor testing (Colon Ortiz et al, 2022, Cell Death Dis). This means that visual acuity, as measured by the OptoDrum's automated optomotor reflex paradigm, can serve as a fast, non-invasive, and longitudinally repeatable biomarker of CNS injury severity and therapeutic response – even in studies where the retina is not the research object of primary interest. No anesthesia, no terminal tissue collection, and no specialized ophthalmological training are required to obtain a quantitative visual acuity value from a mouse or rat within four minutes of placing it in the instrument.
Animal Models

What Are Common Animal Models For CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke?

  • Optic nerve crush (ONC): The most widely used acute optic nerve injury model. A calibrated forceps applies controlled, reproducible pressure to the optic nerve posterior to the eye, severing axons without transecting the meninges. RGC death begins within 48 hours and reaches near-complete loss by 14-21 days. Visual function declines rapidly and is detectable by optomotor testing within days of injury. ONC is the reference paradigm for studying axon degeneration, neuroprotection, and regeneration, and Striatech publications have used it extensively alongside OptoDrum (Baya Mdzomba et al, 2020)(Liu et al, 2023)(Varadarajan et al, 2023).
  • Optic nerve transection (ONT): Complete severing of the optic nerve; produces more severe and rapid RGC death than ONC. Used when complete elimination of axonal input is required, for example in regeneration studies where re-growth of axons through a full transection gap is the experimental endpoint. Visual function is typically abolished bilaterally within one week.
  • Retinal ischemia-reperfusion (I/R) injury: Acute elevation of intraocular pressure to supra-systolic levels (90-100 mmHg) for 45-120 minutes, followed by reperfusion. Replicates the vascular occlusion-reperfusion pathophysiology of retinal artery occlusion, ischemic optic neuropathy, and anterior ischemic optic neuropathy. RGC death, inner plexiform layer thinning, and visual function loss are all quantifiable within 7-14 days. Visual acuity measured by OptoDrum has been used as a functional correlate of I/R severity (Zhao et al, 2025)(Kim et al, 2024).
  • Blast injury / blast TBI: Air-pressure-wave based or shock-tube models that replicate occupational or combat blast exposure. Produces diffuse axonal injury and secondary retinal pathology including RGC loss, optic nerve damage, and measurable visual function deficits (Harper et al, 2024)(Harper et al, 2022). Visual outcomes are dose-dependent and detectable by optomotor testing before overt structural damage is apparent.
  • Controlled cortical impact (CCI) / weight-drop TBI: Models of blunt-force TBI that produce cortical contusion and secondary white matter damage. Retinal and visual pathway injury has been documented as a secondary consequence, and visual readouts can serve as non-invasive indicators of injury severity and repair.
  • Middle cerebral artery occlusion (MCAo) stroke: Transient or permanent focal cerebral ischemia. Secondary neurovascular injury to the visual pathway, including optic tract and retinal ganglion cell layer, produces visual deficits measurable by optomotor testing (Colon Ortiz et al, 2022)(Yu et al, 2022).
  • Optic nerve ligation and optic nerve pressure injury variants: Less commonly used alternatives to ONC offering controllable graded injury levels. Visual acuity deficits correspond to injury severity and can be tracked longitudinally.
Research Questions

How Can Striatech Tools support Your Study?

Select a question that matches your research objective to see which instruments are relevant, what challenge they address, and what the published evidence shows.
01
How Can I Measure Visual Dysfunction After Optic Nerve Crush, Retinal Ischemia-Reperfusion, and TBI?
Audience A - Vision-focused
Audience B - CNS/Systemic

Quick Answer

The OptoDrum automates visual acuity and contrast sensitivity measurement via the optomotor reflex (OMR) in awake, freely moving rodents, providing a non- invasive, longitudinally repeatable endpoint for all three major acute injury paradigms – optic nerve crush, retinal I/R, and TBI – without requiring animal training or anesthesia. A full measurement takes approximately four minutes per animal. When rod-mediated (scotopic) function is also of interest, the ScotopicKit extension enables testing under near-dark conditions, detecting deficits not visible under standard photopic testing.

The challenge

Acute CNS injury models present a specific measurement dilemma: the injury evolves rapidly across a narrow time window (hours to days post-insult), the therapeutic intervention window is equally narrow, and the most informative biological question – whether a given intervention preserves or rescues function – requires repeated measurements from the same animal across multiple time points. Traditional functional assessment in rodents relies either on terminal approaches (ERG, histological RGC counts, retrograde labeling) that preclude longitudinal tracking, or on electrophysiological methods (VEP, pattern ERG) that require anesthesia and trained personnel, introduce measurement variability, and cannot easily be performed daily. For researchers primarily studying TBI or stroke, adding a dedicated ophthalmological workflow to an already complex surgical and behavioral protocol often represents an insurmountable logistical barrier. The optomotor reflex resolves this dilemma. It is mediated by a subcortical circuit – the accessory optic system and nucleus of the optic tract – that is distinct from the visual cortex and does not require training or anesthesia. Visual acuity measured by OMR reflects the integrity of the retina-to-brainstem projection, which is the first pathway damaged in optic nerve injury and I/R, and a sensitive indicator of secondary retinal injury in TBI. Optomotor testing has been validated as a functional endpoint in ONC models, where acuity loss closely tracks RGC death, and has been adapted to I/R injury paradigms where it reliably detects deficits within 7-14 days of ischemic insult. For TBI research specifically, Harper et al (2024) demonstrated that OptoDrum can document dose-dependent visual acuity and contrast sensitivity deficits across graded blast exposure conditions, detecting functional differences between exposure groups before histological RGC loss becomes statistically significant (Harper et al, 2024, Exp Eye Res). This sensitivity to sub-threshold injury makes the OMR particularly valuable as an early-warning functional screen in models where the full extent of retinal damage takes days to weeks to manifest. For a focused discussion of retinal ganglion cell dysfunction as a functional endpoint, see also the Retinal Ganglion Cell Dysfunction application page.

How Striatech products help

OptoDrum
Automated, non-invasive measurement of spatial visual acuity (cycles per degree) and contrast sensitivity via the optomotor reflex. Applicable in ONC, I/R, and TBI models; longitudinally repeatable without anesthesia; full measurement in approximately 4 minutes per animal.
AcuiSee
Provides a cortically mediated, operant visual acuity endpoint for acute CNS injury models. Assesses whether optic nerve crush, retinal ischaemia, or TBI impairs learned visual discrimination and suprathreshold visual perception, a cortical dimension the subcortical optomotor reflex does not capture.
ScotopicKit
Extends OptoDrum testing to scotopic (rod-mediated) conditions in steps of 1 log unit luminance. Relevant when inner retinal I/R injury or secondary degeneration also affects rod photoreceptor pathways, or when night-vision impairment is of specific clinical interest.
DarkAdapt
Light-tight, ventilated housing box for dark-adapting animals prior to scotopic OMR testing. Ensures reproducible dark-adaptation in standard laboratory lighting conditions before ScotopicKit testing.
Non-aversive Animal Platform
Accessory platform for OptoDrum that reduces handling stress during testing. Particularly relevant for post-surgical animals (post-ONC, post-I/R) or debilitated animals following TBI, where conventional restraint or handling may confound behavioral responses.

Evidence from the Literature

  • Remlinger et al (2023) Neurol. Neuroimmunol. Neuroinflamm.
    Feature →
  • Harper et al (2024) Exp Eye Res.
    Using the OptoDrum in a murine blast-TBI model, Harper and colleagues documented dose-dependent visual acuity and contrast sensitivity deficits as a function of blast exposure number and intensity. The study demonstrated that functional visual deficits could be quantified before overt structural damage was apparent, validating the OMR as a sensitive early endpoint in blast- TBI research.
  • Zhao et al (2025) Invest Ophthalmol Vis Sci.
    OptoDrum was used to establish visual function baselines and track post-I/R deficits in a complement signaling study, demonstrating that optomotor-measured visual acuity is a sensitive correlate of complement-driven RGC dysfunction after retinal ischemia-reperfusion injury.
  • Prusky and Douglas (2004) Invest Ophthalmol Vis Sci.
    The foundational study establishing the automated optomotor reflex paradigm for measuring visual acuity and contrast sensitivity in mice and rats. A custom optomotor apparatus was used in this methods-validation study. Striatech's OptoDrum delivers the same endpoint.
02
Does Neuroprotective Treatment Preserve or Rescue Visual Function After Acute Optic Nerve Injury?
Audience A - Vision-focused
Audience B - CNS/Systemic

Quick Answer

Yes – multiple neuroprotective strategies, including antibody therapy against the axon growth inhibitor Nogo-A, erythropoietin administration, and antioxidant treatment, have been shown to preserve optomotor-measured visual acuity after acute optic nerve injury in rodents. The OptoDrum provides the functional readout that confirms whether a given intervention translates RGC survival into behaviorally meaningful visual preservation, and its non-invasive, repeatable design is ideally suited to the multi-time-point treatment studies that neuroprotection research requires.

The challenge

A central problem in translational neuroprotection research is the gap between histological RGC survival and functional preservation of vision. Neuroprotective agents routinely improve RGC counts in post-injury histology, but a statistically significant improvement in cell number does not automatically confirm that the surviving cells retain functional connectivity or that the animal's visual performance is meaningfully improved. This disconnect between structure and function has contributed to a failure rate in translating preclinical neuroprotection findings to clinical benefit. Incorporating a direct functional measure of visual performance – rather than relying solely on anatomical endpoints – provides a critical reality check on the translational value of a candidate neuroprotective treatment. The ONC model is ideal for neuroprotection studies because it delivers a calibrated, acute insult with a predictable time course of RGC loss (peak apoptosis at 7-14 days), allowing precisely timed intervention windows. The post-injury visual acuity decline is equally predictable, and the OptoDrum can detect the effect of a neuroprotective intervention on this decline within the first week post-injury, dramatically accelerating the feedback cycle for candidate drug screening. See also the Retinal Ganglion Cell Death application page for focused discussion of RGC death mechanisms and endpoints. Because neuroprotection strategies validated in ONC often have implications for glaucoma and chronic optic neuropathies, see also the Glaucoma and Optic Nerve Neurodegeneration application page. For therapeutic rescue approaches aimed at restoring vision, see the Maintaining and Restoring Vision application page.

How Striatech products help

OptoDrum
Provides the primary functional endpoint in neuroprotection studies: spatial visual acuity and contrast sensitivity measured longitudinally post-injury and post-treatment. Detects treatment-associated functional preservation or rescue without requiring animal sacrifice at each time point.
AcuiSee
Provides a cortically mediated, operant visual acuity endpoint for neuroprotection studies after acute optic nerve injury. Confirms whether neuroprotective interventions preserve learned visual discrimination and cortical visual processing, complementing the subcortical reflex readout from OptoDrum.
Non-aversive Animal Platform
Minimizes handling-related stress in post-surgical or debilitated animals, ensuring that apparent treatment differences in optomotor performance reflect genuine functional status rather than handling-induced variability.

Evidence from the Literature

  • Remlinger et al (2023) Neurol. Neuroimmunol. Neuroinflamm.
    Feature →
  • Baya Mdzomba et al (2020) Cell Death Dis.
    Journal Club →
    This study showed that anti-Nogo-A antibody treatment following acute optic nerve injury leads to significantly improved optomotor-measured visual acuity compared to controls, establishing OptoDrum as the primary functional endpoint for evaluating this regeneration-promoting biologic.  
  • Eghbali et al (2023) Cell J.
    Systemic EPO treatment after acute optic nerve injury significantly reduces RGC apoptosis and preserves optomotor-measured visual function. OptoDrum confirmed that the structural neuroprotective benefit of EPO translated to a functionally meaningful improvement in visual performance.
  • Li et al (2023) Life Sci. Alliance
    Feature →
    Li and colleagues reported that ascorbic acid (vitamin C) provides antioxidant neuroprotection in an optic nerve damage model, with OptoDrum confirming retained visual acuity in vitamin C- treated animals relative to controls. This study adds to a growing body of evidence that antioxidant strategies targeting oxidative stress – a key mediator of secondary RGC death after acute nerve injury – have functionally measurable neuroprotective effects.
03
Does Axon Regeneration After Optic Nerve Crush Translate to Functional Vision Recovery?
Audience A - Vision-focused

Quick Answer

Partial but significant functional vision recovery is achievable in rodent ONC models when axon-regeneration-promoting strategies are combined with measures that preserve RGC viability. OptoDrum provides the behavioral endpoint that answers the critical translational question: does any observed anatomical axon regrowth actually restore visual performance? Several published studies using OptoDrum document functional recovery above the post-ONC floor, including with activity-dependent stimulation, zinc transporter deletion, and dopaminergic neuromodulation strategies.

The challenge

Adult CNS axons do not spontaneously regenerate after injury. The optic nerve after crush presents a dual barrier to recovery: the inhibitory extracellular environment (Nogo-A, MAG, and myelin-associated inhibitors) and the intrinsically low regenerative capacity of adult RGCs after their developmental growth window has closed. A substantial body of research has now produced partial regeneration in ONC models through PTEN deletion, CNTF treatment, Nogo-A antibodies, electrical stimulation, and various combinatorial approaches. However, demonstrating anatomical axon regrowth is not sufficient to establish functional recovery: regenerating axons must reach appropriate brain targets, form functional synapses, and ultimately restore a measurable behavioral visual response. This final behavioral validation step is precisely what the OptoDrum provides, and it is the step most frequently missing from publications that rely solely on immunohistochemical axon counting. For researchers in the regeneration field, the OptoDrum's most important feature is its sensitivity to partial recovery. Because the optomotor reflex is graded – the software continuously adjusts stimulus spatial frequency to find the precise acuity threshold – it can detect incremental improvements above the post-injury floor, even when visual function is far from normal. This sensitivity to partial recovery is critical in a field where full restoration of vision is not yet achievable and where detecting even modest functional gains is scientifically informative. For focused discussion of axon degeneration mechanisms, see the Axon Degeneration cluster page. For the broader context of restoring visual function after injury, see the Maintaining and Restoring Vision application page, which covers optogenetics, gene therapy, and other restoration strategies alongside regenerative approaches.

How Striatech products help

OptoDrum
Measures visual acuity and contrast sensitivity longitudinally post-ONC, providing a graded, quantitative behavioral measure of functional recovery that complements anatomical axon tracing and RGC counting. Can detect partial recovery above the post-injury floor. Repeated measurement is possible as frequently as daily without animal distress.
AcuiSee
The critical cortical validation endpoint for axon regeneration studies: confirms whether regenerated RGC axons re-establish cortical visual processing and support learned visual discrimination. This cortical confirmation goes beyond the subcortical optomotor reflex recovery measured by OptoDrum.
Non-aversive Animal Platform
Facilitates reliable optomotor testing in animals that may be post-surgical or handling-averse following repeated procedures associated with regeneration protocols (injections, electrical stimulation, etc.).

Evidence from the Literature

  • Remlinger et al (2023) Neurol. Neuroimmunol. Neuroinflamm.
    Feature →
  • Varadarajan et al (2023) Cell Rep.
    Journal Club →
    Enhancing activity in postsynaptic visual target neurons promotes RGC axon regeneration after ONC. OptoDrum was used to confirm that this activity-dependent approach produced significant partial visual function recovery. The behavioral endpoint confirmed that regenerating axons restore physiologically functional connectivity.
  • Liu et al (2023) Neural Regen Res.
    Genetic ablation of ZnT3, which reduces vesicular zinc release at synaptic terminals and thereby limits zinc-mediated excitotoxic RGC death, both reduces RGC apoptosis and promotes axon regeneration in the ONC model. OptoDrum confirmed that ZnT3 knockout mice retained significantly better visual acuity than wild-type controls after crush.
  • Zhang et al (2024) Sci Adv.
    Dopaminergic neuromodulation was identified by amacrine cells as a contributor to functional visual recovery after ONC. The study highlights that intraretinal circuit mechanisms contribute to functional recovery independently of axon regrowth per se, and that OptoDrum can detect recovery driven by mechanisms proximal to the eye.
04
Can Visual Acuity Serve as a Non-Invasive Biomarker for CNS Injury Severity in TBI and Stroke Models?
Audience A - Vision-focused
Audience B - CNS/Systemic

Quick Answer

Yes. Published studies in blast TBI and ischemic stroke models demonstrate that optomotor-measured visual acuity correlates with the severity of CNS neurovascular injury and retinal inflammation, providing a rapid, non-invasive, quantitative readout of injury severity without requiring dedicated ophthalmological instruments or anesthesia. This makes the OptoDrum directly relevant to TBI and stroke researchers who do not primarily study vision but who can benefit from an objective behavioral correlate of CNS injury and treatment response.

The challenge

TBI and stroke researchers face a persistent challenge in translating molecular and histological endpoints to behavioral outcomes. Standard behavioral batteries for TBI and stroke in rodents – rotarod, beam walk, Morris water maze, novel object recognition – assess motor and cognitive function, which recover unpredictably and are confounded by non-neurological factors including body weight, anxiety, and pain. These tests require trained observers, produce high inter-animal variability, and are often insensitive to mild-to-moderate injury conditions. Visual function offers an alternative behavioral axis: it is anatomically orthogonal to motor and cognitive circuits, is served by a well-characterized, reproducible subcortical pathway, and can be measured automatically in four minutes with no experimenter interpretation required. The retinal vasculature is anatomically contiguous with the cerebral vasculature, and retinal neurovascular injury is now well established as a reliable proxy for cerebral neurovascular status after both ischemic stroke (Colon Ortiz et al, 2022) and blast TBI (Harper et al, 2022). In both paradigms, retinal inflammatory activation – microglial priming, complement deposition, leukocyte infiltration – mirrors pathological processes in the brain parenchyma, and the functional visual deficit produced reflects the cumulative effect of this cascade on RGC pathway integrity. Since the retina can be assessed non-invasively and repeatedly, it provides a window onto CNS injury status that no other tissue can match in the living animal. For a broader treatment of the neurovascular angle, see the Vascular and Metabolic Disease application page.

How Striatech products help

OptoDrum
Provides a fully automated, observer-independent visual acuity readout that can be incorporated into any TBI or stroke behavioral battery without ophthalmological expertise. Non-invasive, repeatable, and sensitive to mild-to-moderate injury conditions. Each test takes less than 10 minutes.
AcuiSee
Provides a cortically mediated visual acuity biomarker for CNS injury severity in TBI and stroke models. Particularly relevant when the injury directly affects cortical processing, as AcuiSee captures impairment in learned visual discrimination that the subcortical optomotor reflex may miss.
Non-aversive Animal Platform
Enables testing of post-TBI animals that may be debilitated, pain-sensitized, or handling-averse following injury surgery. The tunnel-lid design allows voluntary entry from the home cage, minimizing stress-related confounds in behavioral measurements.

Evidence from the Literature

  • Remlinger et al (2023) Neurol. Neuroimmunol. Neuroinflamm.
    Feature →
  • Harper et al (2022) Exp. Eye. Res.
    Retinal microglial activation, inflammatory cell infiltration, and RGC loss following blast TBI were characterized. The study established that retinal immune responses after blast TBI produce functionally measurable visual deficits, quantified with the OptoDrum, validating the OMR as a biomarker of blast-induced CNS injury severity.
  • Colón Ortiz et al (2022) Cell. Death Dis.
    Journal Club →
    Neurovascular injury following experimental stroke produces measurable visual function deficits detectable by OptoDrum, demonstrating the tool's utility as a non-invasive CNS injury biomarker in a primarily vascular injury paradigm.
  • Yu et al (2022) Biomaterials
    Using OptoDrum, functional visual recovery was documented as an outcome measure in a cell-based neuroprotection study following ischemia-reperfusion, connecting stroke-related ischemia to a quantifiable visual endpoint and demonstrating that cell therapy can shift this endpoint toward recovery.
05
Which Molecular Pathways Drive Retinal Ganglion Cell Loss and Visual Dysfunction After Acute Ischemia-Reperfusion Injury?
Audience A - Vision-focused
Audience B - CNS/Systemic

Quick Answer

Two well-characterized death pathways operate in parallel after retinal I/R: complement-dependent neuroinflammatory amplification via C3/C3aR signaling and RIPK1-mediated necroptosis. Both have been demonstrated to produce OptoDrum-measurable visual acuity deficits in rodent I/R models, and pharmacological or genetic intervention in both pathways preserves functional visual performance. The OptoDrum provides the in vivo functional readout that ties these mechanistic findings to physiologically meaningful visual outcomes.

The challenge

Retinal I/R injury activates multiple parallel and intersecting death pathways within hours of reperfusion, creating an intervention landscape that is mechanistically rich but therapeutically complex. The primary insult – sudden restoration of blood flow after ischemia – triggers oxidative burst, mitochondrial permeability transition, and excitotoxic glutamate release, which in turn engage both apoptotic cascades and the more recently characterized necroptotic pathway (via RIPK1/RIPK3/MLKL). Simultaneously, complement activation deposits C3 on stressed RGCs, triggering C3aR-mediated inflammatory amplification and recruiting peripheral immune cells. Researchers targeting either arm of this response need a reliable functional endpoint that confirms whether their intervention actually protects the RGC-to-brain visual axis, rather than simply reducing a histological marker. Visual acuity measured by OptoDrum serves this purpose: it is a direct readout of the integrated functional state of the inner retina and optic projection, sensitive to the degree of RGC loss and synaptic dysfunction produced by the injury. Cross-references are warranted here: the neuroinflammatory arm of I/R injury closely overlaps with chronic neuroinflammatory disease mechanisms; see the Neuroinflammation and Autoimmune CNS Disease application page. For glaucoma-related IOP elevation and its overlap with I/R models, see the Glaucoma and Optic Nerve Neurodegeneration application page. For the dedicated cluster page on this injury modality, see the Retinal Ischemia-Reperfusion Injury cluster page.

How Striatech products help

OptoDrum
Measures the functional consequence of I/R-induced RGC death on the optomotor reflex pathway, providing a quantitative, non-invasive readout of how much visual acuity is lost after injury and how much is preserved by mechanistic intervention. Longitudinal testing tracks the temporal evolution of functional decline.
AcuiSee
Provides a cortically mediated, operant visual acuity endpoint for ischaemia-reperfusion RGC loss studies. Assesses whether pathway-specific neuroprotective interventions preserve learned visual discrimination, complementing the subcortical reflex readout from OptoDrum.
ScotopicKit
When inner retinal I/R injury also produces secondary photoreceptor degeneration (which occurs in prolonged ischemia protocols), the ScotopicKit can assess whether rod-mediated visual function is additionally compromised, providing a more complete functional profile of the injury.

Evidence from the Literature

  • Remlinger et al (2023) Neurol. Neuroimmunol. Neuroinflamm.
    Feature →
  • Zhao et al (2025) Invest Ophthalmol Vis Sci.
    Complement C3/C3aR signaling drives RGC dysfunction after retinal I/R injury, and that inhibiting this pathway preserves OptoDrum-measured visual function. The study establishes complement activation as a key mediator of the neuroinflammatory amplification that follows the primary ischemic insult.
  • Kim et al (2024) Cell Death Differ.
    Journal Club →
    Feature →
    Pharmacological inhibition of RIPK1, a master regulator of necroptosis and apoptosis, significantly protects RGCs from death following I/R and preserves visual acuity measured with the OptoDrum. This study is particularly noteworthy because it demonstrates that blocking a non-apoptotic, necrotic death modality (one that is not targeted by classical caspase inhibitors) provides functional visual protection.
06
How Do I Track Injury Progression Over Time and Identify the Therapeutic Window in Acute CNS Injury Models?
Audience A - Vision-focused

Quick Answer

The OptoDrum's non-invasive, repeatable design allows daily or weekly longitudinal tracking of visual function decline and recovery in individual animals, making it uniquely suited to characterizing the temporal dynamics of acute CNS injury and defining the window within which an intervention must be applied to be effective. Because no anesthesia is required and each test takes approximately four minutes, high-frequency longitudinal protocols are practically feasible in ways that terminal or anesthesia-dependent methods are not.

The challenge

Defining the therapeutic window – the time span after injury during which a given intervention can still produce a meaningful benefit – is one of the most clinically consequential and experimentally challenging questions in acute CNS injury research. Window definition requires functional measurements at multiple closely spaced time points in the same animal, spanning the period from the acute insult through the peak of secondary degeneration and, ideally, into any spontaneous or treatment-induced recovery phase. Terminal methods such as RGC counting or retinal ganglion cell layer thickness measurement by OCT provide snapshots at fixed post-injury times but preclude tracking within the same animal across that window. Electrophysiological methods (ERG, VEP) provide functional data but require anesthesia, limiting their feasibility as frequent-measurement tools and introducing variability from anesthetic depth. The OptoDrum resolves these constraints. Because the optomotor reflex does not require anesthesia, training, or any specialized preparation beyond briefly placing the animal in the testing chamber, it is practically feasible to measure visual acuity every 24 to 48 hours post-injury in ONC, I/R, or TBI models. This high-frequency tracking capability enables precise characterization of the inflection point at which functional decline plateaus or begins to recover – the key datum for setting the biological window for intervention. Multiple published studies in the Striatech corpus have used this longitudinal design, with some protocols tracking visual acuity from day 3 to day 28 or beyond post-ONC. A secondary benefit of longitudinal functional tracking is the ability to perform intra-animal statistical analyses, reducing the number of animals needed to achieve statistical power (a direct 3Rs Reduction benefit). Animals that serve as their own pre-injury control provide substantially more information per animal than cross-sectional designs in which each time point requires a separate cohort. The non-aversive animal platform further refines this benefit by minimizing handling-associated variability, ensuring that repeated measurements across weeks reflect genuine biological changes rather than behavioral adaptation to stress.

How Striatech products help

OptoDrum
Enables high-frequency longitudinal tracking of visual acuity and contrast sensitivity within individual animals post-injury, without anesthesia or terminal intervention. Provides pre-injury baselines and post-injury time courses suitable for therapeutic window determination. Each test takes less than 10 minutes.
AcuiSee
Provides a cortically mediated, operant visual acuity endpoint for longitudinal injury progression tracking. Reveals the time course of cortical visual processing recovery and therapeutic window boundaries, complementing the subcortical reflex trajectory from OptoDrum.
Non-aversive Animal Platform
Reduces handling stress in repeatedly tested animals, improving reproducibility of longitudinal measurements and ensuring that detected changes reflect biological status rather than behavioral habituation or stress-related variability.
DarkAdapt
When scotopic function is tracked longitudinally (for example, to detect secondary rod photoreceptor effects in I/R injury), the DarkAdapt ensures consistent dark-adaptation duration across all time points, a prerequisite for reproducible scotopic OMR results.
ScotopicKit
Extends longitudinal functional tracking to rod-mediated vision, enabling detection of secondary outer retinal involvement at later stages of degeneration that would be missed by photopic testing alone.

Evidence from the Literature

  • Remlinger et al (2023) Neurol. Neuroimmunol. Neuroinflamm.
    Feature →
  • Prusky and Douglas (2004) Invest Ophthalmol Vis Sci.
    This foundational methods paper established the quantitative optomotor reflex paradigm for mice and rats and documented its sensitivity to retinal injury over time. Striatech's fully automated OptoDrum delivers the equivalent measurement.
Product Fit

Summary: Striatech Products supporting your research questions

Research Question OptoDrum ScotopicKit AcuiSee Photorefractor Keratometer DarkAdapt Non-aversive Platform
Measuring visual dysfunction (ONC, I/R, TBI) Yes Yes Yes Yes (with ScotopicKit) Yes
Neuroprotective treatment Yes Yes Yes
Axon regeneration / functional recovery Yes Yes Yes
TBI / stroke CNS biomarker Yes Yes Yes
I/R molecular pathways Yes Yes Yes Yes (with ScotopicKit)
Therapeutic window / longitudinal tracking Yes Yes Yes Yes (with ScotopicKit) Yes
AcuiSee (operant conditioning, cortical visual processing) is appropriate in paradigms specifically targeting cortical visual recovery after TBI or when learning-dependent visual function needs to be distinguished from the subcortical OMR. Photorefractor and Keratometer measure refractive state and corneal curvature, respectively; these endpoints are not primary outcomes in acute trauma models unless ocular structural changes (for example, I/R-associated anterior segment effects) are of specific interest.
Measurement Modalities

Measuring Functional Visual Outcomes in CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke: How Do Available Methods Compare?

The table below compares the OptoDrum-based optomotor reflex approach with other commonly used visual and functional readouts in acute CNS injury research.
Modality What It Measures Invasiveness Anesthesia Required Longitudinal Repeatability Training / Expertise Required Automation 3Rs Impact
OptoDrum (OMR) Visual acuity and contrast sensitivity via subcortical reflex; retina-to-brainstem pathway integrity Non-invasive No Daily if required; no upper limit Minimal; no ophthalmological training needed Fully automated Replaces terminal endpoints; enables intra-animal longitudinal designs (Reduction)
Scotopic OMR (OptoDrum + ScotopicKit) Rod-mediated visual acuity and contrast sensitivity; outer retinal integrity Non-invasive No Daily if required Minimal; dark-adaptation protocol required Fully automated As above; extends coverage to outer retinal compartment
AcuiSee (operant) Visual acuity and contrast sensitivity via cortically mediated choice behavior Non-invasive No Yes, after training is established Moderate; training phase 10-14 days; requires behavioral infrastructure Moderate Animal welfare benefit from food-reward rather than aversive design; training phase adds burden
Flash ERG (full-field) Mass photoreceptor and inner retinal response (a-wave, b-wave); outer and inner retinal function Minimally invasive (corneal electrode) Yes (typically) Limited by anesthesia burden; typically weekly or less Moderate to high; electrophysiology expertise required Moderate Anesthesia adds welfare burden; enables quantification of outer retinal function not captured by OMR
Pattern ERG (PERG) RGC-specific electrophysiological response; inner retinal function Minimally invasive Yes (typically) Limited by anesthesia; typically weekly or less High; specialized equipment and expertise required Low to moderate Anesthesia burden; but provides RGC-specific inner retinal readout complementary to OMR
Visual evoked potential (VEP) Cortical visual processing; requires functional projection from retina through LGN to V1 Invasive (cortical electrodes) Yes Low; electrode implantation limits acute studies; chronic implants possible High; surgical implantation and neurophysiology expertise required Low Surgical burden; limited longitudinal repeatability; appropriate when cortical processing specifically requires assessment
OCT (optical coherence tomography) Retinal layer thickness; structural readout of RGC layer and nerve fiber layer atrophy Non-invasive (mydriasis typically required) Typically yes (for immobilization) Weekly or biweekly feasible Moderate; dedicated small-animal OCT and image analysis expertise Semi-automated Structural rather than functional; complements OMR by quantifying anatomical degeneration
Histological RGC counts (RBPMS, Brn3a) Absolute surviving RGC numbers; retinal flat-mount quantification Terminal Yes (terminal procedure) None (terminal) Moderate; immunohistochemistry and cell counting expertise required Semi-automated (automated counting algorithms available) Terminal; cannot be combined with longitudinal behavioral endpoints at same time points
Neurological deficit scoring (mNSS, rotarod) Motor and sensorimotor function; general neurological status in TBI/stroke Non-invasive No Yes Moderate; training and standardization required for inter-rater reliability Low (observer-dependent) Complementary to visual readouts; does not capture visual pathway damage
Striatech's OptoDrum is best understood as a complement to, not a replacement for, electrophysiological and structural readouts. Its key competitive advantages in the acute injury context are non-invasiveness, full automation, longitudinal repeatability without anesthesia burden, and the ability to provide a quantitative functional endpoint without ophthalmological specialist involvement. For researchers adding a visual readout to an existing TBI or stroke protocol, OptoDrum is the lowest-barrier entry point to quantitative visual function assessment.
Supported by Striatech Products

Publications on CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke

Keep exploring

Related application areas, neighbouring research chapters, and the questions researchers ask most.

Research Chapter

CNS Trauma and Acute Injury: TBI, Optic Nerve Injury, Stroke

Mechanical, ischemic, and blast injuries that drive rapid, often irreversible damage to CNS neurons and axons. Optic nerve crush, retinal I/R, and TBI models share core injury cascades and yield directly quantifiable visual outcomes.

8
Application Areas
6
FAQs answered
Part of CNS & Neurodegeneration

Main Application Areas

Traumatic Brain Injury (TBI)

Additional Topics

Axon Degeneration
Neuroinflammation
Neurovascular Injury
Optic Nerve Damage
Optic Nerve Regeneration
Retinal Ischemia-Reperfusion Injury
Stroke